Welcome to our dedicated page for Stepan SEC filings (Ticker: SCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stepan Company filings document the regulatory record for a specialty and intermediate chemicals manufacturer whose common stock trades on the New York Stock Exchange under symbol SCL. Its 8-K filings report operating results, dividend declarations, material-event disclosures, capital-structure information and exit or disposal activities tied to manufacturing and efficiency initiatives.
Stepan proxy and annual-meeting filings cover director elections, advisory compensation votes, auditor ratification, executive compensation governance and benefit-plan matters. The filing record also includes disclosure on restructuring charges, asset write-downs, decommissioning costs and other governance or financial matters reported through current reports and proxy materials.
Stepan Company executive Sean Thomas Moriarty reported RSU vesting transactions and related tax withholding. On March 3 and 4, 2026, restricted stock units converted into common shares per award terms, and a portion of the resulting stock was withheld to cover tax liabilities, with remaining shares increasing his direct ownership.
Stepan Company executive Sean Thomas Moriarty reported multiple equity awards and updated holdings. On March 2, 2026, he was granted 6,440 Stock Appreciation Rights, 2,247 performance shares, and 4,495 restricted stock units, each generally vesting ratably over three years beginning on that grant date.
The performance shares vest upon certification that Stepan Company meets performance goals for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.51 per share as an award, bringing his direct common stock holdings to 14,205.2335 shares and his indirect holdings via the ESOP II Trust to 4,478.351 shares. A prior Form 4 incorrectly stated the Stock Appreciation Right amount and is corrected in this amendment.
Stepan Co vice president, general counsel and secretary Shawn G. Lisle reported multiple equity awards. On March 2, 2026, he received 4,495 restricted stock units, 2,247 performance shares and 6,440 stock appreciation rights, all as grants with no cash paid. On February 27, 2026, he also acquired 25.544 shares of common stock at $52.51 per share as an award. The RSUs vest in equal portions over three years, while the performance shares vest if Stepan meets specified performance goals for a period ending on December 31, 2028.
Stepan Company executive Andrea Jean Barry, VP & CHRO, reported multiple stock-based awards. On March 2, 2026, she acquired 4,495 restricted stock units, 2,247 performance shares, and 6,440 stock appreciation rights, all at a stated price of $0.00 per unit.
The RSUs vest ratably over three years starting on the grant date. The performance shares each represent one share of common stock and vest only if Stepan meets specified performance goals for a performance period ending on December 31, 2028. On February 27, 2026, she was also granted 16.464 shares of common stock at $52.51 per share.
Stepan Company executive Robert Joseph Haire, EVP, Supply Chain, reported multiple equity awards. On March 2, 2026, he acquired 5,993 Restricted Stock Units, 2,996 Performance Shares, and 8,586 Stock Appreciation Rights as grant or award acquisitions, all at a stated price of $0.0000 per unit.
Each RSU represents a contingent right to receive one share of Stepan common stock and vests ratably over three years beginning on the grant date. The performance shares vest upon certification that Stepan achieves specified performance goals for the performance period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock as a grant or award, and an indirect holding of 90.269 common shares is shown as held by ESOP II Trust.
Stepan Company executive Sean Thomas Moriarty, VP & GM Surfactants, reported multiple equity awards. On March 2, 2026, he was granted 7,155 Stock Appreciation Rights that vest ratably over three years, 4,495 Restricted Stock Units, and 2,247 performance shares, each representing a contingent right to one share of Stepan common stock.
The performance shares vest upon certification that Stepan achieved specified performance goals for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.5100 per share. The filing notes an additional 4,478.3510 common shares held indirectly through an ESOP II Trust.
STEPAN CO reported that executive Richard Finn Stepan, Vice President and General Manager, Polymers, received several equity incentives. On March 2, 2026, he was granted 7,155 stock appreciation rights that vest ratably over three years, beginning on that date.
He also acquired 2,497 performance shares and 4,994 restricted stock units, each representing a contingent right to receive one share of Stepan common stock. The performance shares vest when the company certifies that performance goals for the period ending December 31, 2028 are achieved, while the RSUs vest ratably over three years from the grant date.
On February 27, 2026, he was awarded 56.765 shares of common stock at $52.51 per share. The filing also lists indirect common stock holdings attributed to his daughter, son, spouse, a trust, and an ESOP II trust, reflecting additional ownership positions reported as indirect.
STEPAN CO reported new equity awards granted to Vice President and Chief Financial Officer Ruben Dario Velasquez. On February 27, 2026, he acquired 35.601 shares of common stock at $52.51 per share as an award. On March 2, 2026, he received grants of 5,993 restricted stock units, 2,996 performance shares, and 8,586 stock appreciation rights, all recorded at a price of $0. Each restricted stock unit and performance share represents a contingent right to receive one share of common stock, with the restricted stock units vesting ratably over three years and the performance shares vesting based on performance goals for a period ending December 31, 2028.
Stepan Co President & CEO Luis Rojo reported equity awards that increase his stake in the company. On March 2, 2026, he received 19,976 Restricted Stock Units, 39,952 performance shares, and a Stock Appreciation Right covering 57,241 shares, all at a stated price of $0.00 per unit.
Each RSU and performance share represents a contingent right to receive one share of Stepan common stock, with RSUs vesting in equal installments over three years and performance shares vesting after certification of performance for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.51 per share, bringing his directly held common stock to 15,697.666 shares, plus 511.83 shares held indirectly through an ESOP II trust.
Stepan Company files its annual report describing a global specialty and intermediate chemicals business organized into Surfactants, Polymers and Specialty Products. It sells mainly to manufacturers rather than directly to consumers, serving cleaning, personal care, construction, agriculture, oilfield and food/pharma markets.
The company highlights environmental and regulatory compliance, spending $9.8 million on related capital projects and $44.9 million on recurring environmental operating costs in 2025. It launched Project Catalyst in February 2026, targeting about $100 million in pre-tax savings over two years through operational and efficiency initiatives.
Management discusses key risks, including hazardous chemical operations, raw material and energy volatility, transportation disruptions, geopolitical tensions, evolving chemical and product regulations, cybersecurity threats and legal liabilities. Stepan also notes significant indebtedness, with long-term notes and a revolving credit facility, and emphasizes strong safety culture, human capital development and a formal enterprise risk management and cybersecurity governance framework.